Abstract
Chlorpyrifos is a moderately toxic organophosphate pesticide. Houses and lawns in the United States receive a total of approximately 20 million annual chlorpyrifos treatments, and 82% of U.S. adults have detectable levels of a chlorpyrifos metabolite (3,5, 6-trichloro-2-pyridinol; TCP) in the urine. The U.S. Environmental Protection Agency has estimated that there are 5,000 yearly reported cases of accidental chlorpyrifos poisoning, and approximately one-fourth of these cases exhibit symptoms. Organophosphates affect the nervous system, but there are few epidemiologic data on chlorpyrifos neurotoxicity. We studied neurologic function in 191 current and former termiticide applicators who had an average of 2.4 years applying chlorpyrifos and 2.5 years applying other pesticides, and we compared them to 189 nonexposed controls. The average urinary TCP level for 65 recently exposed applicators was 629.5 microg/L, as compared to 4.5 microg/L for the general U.S. population. The exposed group did not differ significantly from the nonexposed group for any test in the clinical examination. Few significant differences were found in nerve conduction velocity, arm/hand tremor, vibrotactile sensitivity, vision, smell, visual/motor skills, or neurobehavioral skills. The exposed group did not perform as well as the nonexposed group in pegboard turning tests and some postural sway tests. The exposed subjects also reported significantly more symptoms, including memory problems, emotional states, fatigue, and loss of muscle strength; our more quantitative tests may not have been adequate to detect these symptoms. Eight men who reported past chlorpyrifos poisoning had a pattern of low performance on a number of tests, which is consistent with prior reports of chronic effects of organophosphate poisoning. Overall, the lack of exposure effects on the clinical examination was reassuring. The findings for self-reported symptoms raise some concern, as does the finding of low performance for those reporting prior poisoning. Although this was a relatively large study based on a well-defined target population, the workers we studied may not be representative of all exposed workers, and caution should be exercised in generalizing our results.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aiuto L. A., Pavlakis S. G., Boxer R. A. Life-threatening organophosphate-induced delayed polyneuropathy in a child after accidental chlorpyrifos ingestion. J Pediatr. 1993 Apr;122(4):658–660. doi: 10.1016/s0022-3476(05)83560-7. [DOI] [PubMed] [Google Scholar]
- Ames R. G., Brown S. K., Rosenberg J., Jackson R. J., Stratton J. W., Quenon S. G. Health symptoms and occupational exposure to flea control products among California pet handlers. Am Ind Hyg Assoc J. 1989 Sep;50(9):466–472. doi: 10.1080/15298668991375001. [DOI] [PubMed] [Google Scholar]
- Bhattacharya A., Shukla R., Dietrich K., Bornschein R., Berger O. Effect of early lead exposure on children's postural balance. Dev Med Child Neurol. 1995 Oct;37(10):861–878. doi: 10.1111/j.1469-8749.1995.tb11939.x. [DOI] [PubMed] [Google Scholar]
- Bowman K. J. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol (Copenh) 1982 Dec;60(6):907–916. doi: 10.1111/j.1755-3768.1982.tb00621.x. [DOI] [PubMed] [Google Scholar]
- Brenner F. E., Bond G. G., McLaren E. A., Green S., Cook R. R. Morbidity among employees engaged in the manufacture or formulation of chlorpyrifos. Br J Ind Med. 1989 Feb;46(2):133–137. doi: 10.1136/oem.46.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burns C. J., Cartmill J. B., Powers B. S., Lee M. K. Update of the morbidity experience of employees potentially exposed to chlorpyrifos. Occup Environ Med. 1998 Jan;55(1):65–70. doi: 10.1136/oem.55.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dick R. B., Bhattacharya A., Shukla R. Use of a computerized postural sway measurement system for neurobehavioral toxicology. Neurotoxicol Teratol. 1990 Jan-Feb;12(1):1–6. doi: 10.1016/0892-0362(90)90105-l. [DOI] [PubMed] [Google Scholar]
- Doty R. L., Marcus A., Lee W. W. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope. 1996 Mar;106(3 Pt 1):353–356. doi: 10.1097/00005537-199603000-00021. [DOI] [PubMed] [Google Scholar]
- Fenske R. A., Elkner K. P. Multi-route exposure assessment and biological monitoring of urban pesticide applicators during structural control treatments with chlorpyrifos. Toxicol Ind Health. 1990 May-Jul;6(3-4):349–371. doi: 10.1177/074823379000600301. [DOI] [PubMed] [Google Scholar]
- Fortier I., Ferraris J., Mergler D. Measurement precision of an olfactory perception threshold test for use in field studies. Am J Ind Med. 1991;20(4):495–504. doi: 10.1002/ajim.4700200405. [DOI] [PubMed] [Google Scholar]
- Garin M. C., James R. W., Dussoix P., Blanché H., Passa P., Froguel P., Ruiz J. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest. 1997 Jan 1;99(1):62–66. doi: 10.1172/JCI119134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hill R. H., Jr, Head S. L., Baker S., Gregg M., Shealy D. B., Bailey S. L., Williams C. C., Sampson E. J., Needham L. L. Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res. 1995 Nov;71(2):99–108. doi: 10.1006/enrs.1995.1071. [DOI] [PubMed] [Google Scholar]
- Humbert R., Adler D. A., Disteche C. M., Hassett C., Omiecinski C. J., Furlong C. E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet. 1993 Jan;3(1):73–76. doi: 10.1038/ng0193-73. [DOI] [PubMed] [Google Scholar]
- Kaplan J. G., Kessler J., Rosenberg N., Pack D., Schaumburg H. H. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology. 1993 Nov;43(11):2193–2196. doi: 10.1212/wnl.43.11.2193. [DOI] [PubMed] [Google Scholar]
- Kilburn K. H., Thornton J. C. Protracted neurotoxicity from chlordane sprayed to kill termites. Environ Health Perspect. 1995 Jul-Aug;103(7-8):690–694. doi: 10.1289/ehp.95103690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kingston R. L., Chen W. L., Borron S. W., Sioris L. J., Harris C. R., Engebretsen K. M. Chlorpyrifos: a ten-year US poison center exposure experience. Vet Hum Toxicol. 1999 Apr;41(2):87–92. [PubMed] [Google Scholar]
- Leviev I., Negro F., James R. W. Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2935–2939. doi: 10.1161/01.atv.17.11.2935. [DOI] [PubMed] [Google Scholar]
- Li W. F., Costa L. G., Furlong C. E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):337–346. doi: 10.1080/15287399309531798. [DOI] [PubMed] [Google Scholar]
- Lotti M., Moretto A., Zoppellari R., Dainese R., Rizzuto N., Barusco G. Inhibition of lymphocytic neuropathy target esterase predicts the development of organophosphate-induced delayed polyneuropathy. Arch Toxicol. 1986 Oct;59(3):176–179. doi: 10.1007/BF00316329. [DOI] [PubMed] [Google Scholar]
- Mackness B., Mackness M. I., Arrol S., Turkie W., Durrington P. N. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br J Pharmacol. 1997 Sep;122(2):265–268. doi: 10.1038/sj.bjp.0701390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nickerson D. A., Kaiser R., Lappin S., Stewart J., Hood L., Landegren U. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8923–8927. doi: 10.1073/pnas.87.22.8923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Malley M. Clinical evaluation of pesticide exposure and poisonings. Lancet. 1997 Apr 19;349(9059):1161–1166. doi: 10.1016/S0140-6736(96)07222-4. [DOI] [PubMed] [Google Scholar]
- Richardson R. J. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: a critical review of the literature. J Toxicol Environ Health. 1995 Feb;44(2):135–165. doi: 10.1080/15287399509531952. [DOI] [PubMed] [Google Scholar]
- Rosenstock L., Keifer M., Daniell W. E., McConnell R., Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. The Pesticide Health Effects Study Group. Lancet. 1991 Jul 27;338(8761):223–227. doi: 10.1016/0140-6736(91)90356-t. [DOI] [PubMed] [Google Scholar]
- Savage E. P., Keefe T. J., Mounce L. M., Heaton R. K., Lewis J. A., Burcar P. J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch Environ Health. 1988 Jan-Feb;43(1):38–45. doi: 10.1080/00039896.1988.9934372. [DOI] [PubMed] [Google Scholar]
- Sim M., Dick R., Russo J., Bernard B., Grubb P., Krieg E., Jr, Mueller C., McCammon C. Are aluminium potroom workers at increased risk of neurological disorders? Occup Environ Med. 1997 Apr;54(4):229–235. doi: 10.1136/oem.54.4.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steenland K., Jenkins B., Ames R. G., O'Malley M., Chrislip D., Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health. 1994 May;84(5):731–736. doi: 10.2105/ajph.84.5.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson W. D. Statistical criteria in the interpretation of epidemiologic data. Am J Public Health. 1987 Feb;77(2):191–194. doi: 10.2105/ajph.77.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]